Differences in tuberculin reactivity as determined in a veterans administration employee health screening program

Clinical and Vaccine Immunology

Volumn 16, Issue 4, 2009, Pages 541-543

  Mehta, Sanjay R ^a,b,c   MacGruder, Cathy ^b   Looney, David ^a,b   Johns, Scott ^b   Smith, Davey M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c Stein Clinical Research Building MC 0711 9500 Gilman Drive ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUBERCULIN;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; HUMAN; MAJOR CLINICAL STUDY; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REPEAT PROCEDURE; SCREENING; SKIN TEST; TUBERCULIN TEST; VETERAN; VETERAN ADMINISTRATION EMPLOYEE HEALTH SCREENING PROGRAM;

EID: 64549125586     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00375-08     Document Type: Article

References (12)

1. Blumberg, H. M., N. White, P. Parrott, W. Gordon, M. Hunter, and S. Ray. 2000. False-positive tuberculin skin test results among health care workers. JAMA 283:2793.
2. Diel, R., R. Loddenkemper, K. Meywald-Walter, S. Niemann, and A. Nien-haus. 2008. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with My-cobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 177:1164- 1170.
3. Ferrara, G., M. Losi, M. Meacci, B. Meccugni, R. Piro, P. Roversi, B. M. Bergamini, R. D'Amico, P. Marchegiano, F. Rumpianesi, L. M. Fabbri, and L. Richeldi. 2005. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 172:631-635.
4. Gillenwater, K. A., S. C. Sapp, K. Pearce, and G. K. Siberry. 2006. Increase in tuberculin skin test converters among health care workers after a change from Tubersol to Aplisol. Am. J. Infect. Control 34:651-654.
5. Jensen, P. A., L. A. Lambert, M. F. Iademarco, and R. Ridzon. 2005. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recommend. Rep. 54:1-141.
6. Kang, Y. A., H. W. Lee, H. I. Yoon, B. Cho, S. K. Han, Y. S. Shim, and J. J. Yim. 2005. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293:2756-2761.
7. Lee, E., and R. S. Holzman. 2002. Evolution and current use of the tuberculin test. Clin. Infect. Dis. 34:365-370.
8. Mazurek, G. H., J. Jereb, P. Lobue, M. F. Iademarco, B. Metchock, and A. Vernon. 2005. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recommend. Rep. 54:49-55.
9. Mori, T., M. Sakatani, F. Yamagishi, T. Takashima, Y. Kawabe, K. Nagao, E. Shigeto, N. Harada, S. Mitarai, M. Okada, K. Suzuki, Y. Inoue, K Tsuyuguchi, Y. Sasaki, G. H. Mazurek, and I. Tsuyuguchi. 2004. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am. J. Respir. Crit. Care Med. 170:59-64.
10. Page, E. H., and R. J. Driscoll. 2007. Evaluation of results from occupational tuberculin skin tests-Mississippi, 2006. MMWR Morb. Mortal. Wkly. Rep. 56:1316-1318.
11. Rupp, M. E., A. W. Schultz, Jr., and J. C. Davis. 1994. Discordance between tuberculin skin test results with two commercial purified protein derivative preparations. J. Infect. Dis. 169:1174-1175.
12. Villarino, M. E., W. Burman, Y. C. Wang, L. Lundergan, A. Catanzaro, N. Bock, C. Jones, and C. Nolan. 1999. Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. JAMA 281:169-171.